FR2898059B1 - Composition phytohormonale contenant de la sauge - Google Patents

Composition phytohormonale contenant de la sauge

Info

Publication number
FR2898059B1
FR2898059B1 FR0650775A FR0650775A FR2898059B1 FR 2898059 B1 FR2898059 B1 FR 2898059B1 FR 0650775 A FR0650775 A FR 0650775A FR 0650775 A FR0650775 A FR 0650775A FR 2898059 B1 FR2898059 B1 FR 2898059B1
Authority
FR
France
Prior art keywords
phytohormonal
composition containing
sage
containing sage
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0650775A
Other languages
English (en)
Other versions
FR2898059A1 (fr
Inventor
Jean Luc Charagnac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Nutreov SAS
Original Assignee
PHYSCIENCE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHYSCIENCE filed Critical PHYSCIENCE
Priority to FR0650775A priority Critical patent/FR2898059B1/fr
Publication of FR2898059A1 publication Critical patent/FR2898059A1/fr
Application granted granted Critical
Publication of FR2898059B1 publication Critical patent/FR2898059B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne une composition phytohormonale comprenant une combinaison d'extraits de végétaux riches en lignanes et d'extrait de sauge, et son utilisation pour le traitement des troubles de la préménopause et de la ménopause.
FR0650775A 2006-03-06 2006-03-06 Composition phytohormonale contenant de la sauge Expired - Fee Related FR2898059B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0650775A FR2898059B1 (fr) 2006-03-06 2006-03-06 Composition phytohormonale contenant de la sauge

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0650775A FR2898059B1 (fr) 2006-03-06 2006-03-06 Composition phytohormonale contenant de la sauge

Publications (2)

Publication Number Publication Date
FR2898059A1 FR2898059A1 (fr) 2007-09-07
FR2898059B1 true FR2898059B1 (fr) 2010-10-08

Family

ID=37311863

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0650775A Expired - Fee Related FR2898059B1 (fr) 2006-03-06 2006-03-06 Composition phytohormonale contenant de la sauge

Country Status (1)

Country Link
FR (1) FR2898059B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8053004B2 (en) 2007-10-08 2011-11-08 Starmaker Products, Llc Ointment for topical treatment of hot flashes and method of use
FR2933300B1 (fr) * 2008-07-02 2012-10-19 Europ Finances Compositions comprenant au moins une lignane et/ou neolignane en association avec un compose actif contre l'acne
FR2940123B1 (fr) * 2008-12-22 2011-04-22 Granions Lab Des Association de composes pour le traitement ou la prevention des bouffees de chaleur et des sueurs engendrees par la menopause

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES62529B2 (en) * 1993-09-09 1995-02-08 Jean Reidy Herbal sachets
US6346267B1 (en) * 2000-07-07 2002-02-12 Wakunaga Of America Co., Ltd. Composition and method for treatment of symptoms associated with insufficient estrogen production

Also Published As

Publication number Publication date
FR2898059A1 (fr) 2007-09-07

Similar Documents

Publication Publication Date Title
TNSN01053A1 (fr) Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique
MA32226B1 (fr) Compositions et leurs procedes de preparation et d'utilisation
TW200740799A (en) Alpha2C adrenoreceptor agonists
MA30766B1 (fr) Formes de dosage pharmaceutiques orales anti-manipulation contenant un analgesique opioide
FR2938437B1 (fr) Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
MA39211A1 (fr) Composés tricycliques comme agents anti-cancers
MA31502B1 (fr) Anticorps anti-notch 1 specifiques a nrr et ses procedes d'utilisation
MA34474B1 (fr) Agonistes de gpr40
MA33608B1 (fr) Composition pharmaceutique, forme galenique, procede pour leur preparation, methodes de traitement et leurs utilisations
TN2010000068A1 (en) Anticorps anti-cd37
RS51563B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ROOSUVASTATIN CALCIUM
MEP8509A (en) Combination treatment for diabetes mellitus
MX338338B (es) Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.
MA35513B1 (fr) Compositions pharmaceutiques comprenant 40 - o - ( 2 - hydroxy) éthyl - rapamycine
DE502005005636D1 (en) Spirocyclische cyclohexan-derivate
MA33743B1 (fr) Compositions comprenant du tramadol et du célécoxib dans le traitement de la douleur
NO20062739L (no) Kontrollert frigivining av topirimat i flytende doseringsform
MA33190B1 (fr) Composes pour le traitement de troubles metaboliques
MA35638B1 (fr) 2-thiopyrimidinones
MA38810A1 (fr) Inhibiteurs de rorc2 méthodes d'utilisation associées
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
MX2009002224A (es) Composicion a base de xantoxilina y su utilizacion en cosmetica.
MA38253B1 (fr) Compositions comprenant de la vortioxétine et du donépézil
MA27539A1 (fr) Nouvelle combinaison synergique contenant du roflumilast et du formoterol
FR2898059B1 (fr) Composition phytohormonale contenant de la sauge

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name

Owner name: LABORATOIRES NUTREOV, FR

Effective date: 20120323

TP Transmission of property

Owner name: LABORATOIRES NUTREOV, FR

Effective date: 20120323

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20211105